Novartis

Saluting Innovation @ Novartis

Saluting Innovation @ Novartis

Saluting Innovation at Novartis for their portfolio transformation focusing the company on leading businesses with innovation power and global scale. April 22, 2014 marked the biggest industry deal since 2009 as Novartis announced their transactions with GlaxoSmithKline (GSK) and Eli Lilly valued at $28.5 billion.